Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 879 | 931 | 879 | 558 | 1059 | 1536 |
Fund Return | -12.1% | -6.87% | -12.1% | -17.66% | 1.15% | 4.39% |
Place in category | 48 | 42 | 48 | 74 | 24 | - |
% in Category | 30 | 23 | 30 | 62 | 54 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Changxin Jinli Trend Stock Fund | 6.6B | 11.20 | -4.99 | 8.89 | ||
Changxin Quant Gr Strat Eq A | 1.08B | 15.22 | -6.44 | - | ||
Changxin Domestic Demand Growth St | 760.62M | 16.87 | -6.83 | 12.64 | ||
Changxin Quantified Pioneer Stock F | 580.08M | 6.50 | -10.31 | 5.62 | ||
Changxin Ruijin Alloc A | 407.88M | -3.12 | -9.42 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid C | 37.43B | -16.74 | -20.80 | - | ||
Zhongou Medical and Health Hybrid A | 37.43B | -16.06 | -20.16 | - | ||
E Healthcare Secotor | 6.35B | -10.07 | -6.18 | 9.22 | ||
Fullgoal Precision Medical Mix Fund | 4.17B | -2.79 | -9.55 | - | ||
China Southern Healthcare Balanced | 3.26B | -15.09 | -18.73 | 7.76 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shenzhen Mindray Bio-Medical | CNE100003G67 | 7.98 | 232.40 | -0.70% | |
Jiangsu Hengrui | CNE0000014W7 | 7.69 | 44.65 | +0.02% | |
Yunnan Baiyao A | CNE0000008X7 | 5.13 | 57.92 | +0.99% | |
Kelun Pharm A | CNE100000PW7 | 4.93 | 28.13 | -0.04% | |
Dong-E E-Jiao A | CNE0000006Y9 | 4.38 | 60.70 | +1.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell |
Technical Indicators | BUY | Strong Sell | Strong Sell |
Summary | Neutral | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review